Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil
MESO•FDA approves new potency assay for commercial Ryoncil
Sept. 24 (Reuters) - Mesoblast Limited MSB.AX:
- FDA approves new potency assay for commercial Ryoncil
- Receives FDA approval for new potency assay for commercial Ryoncil product
Further company coverage: MSB.AX




